FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $386,100 | +42.9% | 117,000 | +23.5% | 0.00% | 0.0% |
| Q1 2023 | $270,095 | -70.5% | 94,770 | -24.7% | 0.00% | -66.7% |
| Q4 2022 | $916,814 | +78.0% | 125,936 | +97.7% | 0.00% | +50.0% |
| Q3 2022 | $515,000 | +270.5% | 63,687 | +125.2% | 0.00% | – |
| Q2 2022 | $139,000 | -83.2% | 28,284 | -19.0% | 0.00% | -100.0% |
| Q1 2022 | $825,000 | -18.6% | 34,900 | -39.1% | 0.00% | 0.0% |
| Q4 2021 | $1,014,000 | +164.1% | 57,300 | +321.3% | 0.00% | +100.0% |
| Q3 2021 | $384,000 | +64.1% | 13,600 | -31.7% | 0.00% | – |
| Q1 2021 | $234,000 | +0.4% | 19,900 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $233,000 | +50.3% | 19,900 | +2.1% | 0.00% | – |
| Q3 2020 | $155,000 | -56.6% | 19,500 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $357,000 | +53.2% | 19,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $233,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $32,054,000 | 14.00% |
| TRV GP IV, LLC | 2,343,154 | $18,956,000 | 11.08% |
| Logos Global Management LP | 1,950,000 | $15,776,000 | 1.94% |
| COWEN AND COMPANY, LLC | 2,347,989 | $18,995,000 | 1.82% |
| VR Adviser, LLC | 1,200,000 | $9,708,000 | 1.50% |
| RA Capital Management | 7,000,000 | $56,630,000 | 1.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,528,000 | $28,542,000 | 1.18% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $1,780,000 | 0.77% |
| RTW INVESTMENTS, LP | 3,985,910 | $32,246,000 | 0.74% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $211,000 | 0.69% |